Share. Moderna was the first company to test a potential experimental vaccine for the coronavirus called mRNA-1273. British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in a handful of deals involving Microsoft billionaire Bill Gates … By Kathryn Underwood. Being so large, we would not expect insiders to own a large proportion of the stock. Updated 2 months ago. Funds that own AstraZeneca also own: Comcast Corporation (CMCSA) Eli Lilly & Co. … Share. Most investors will most likely be interested in these assets. You are now leaving AstraZeneca.com. Year-to-date, the stock has risen by 1.5 percent as of Nov. 2. Custom. Among the five Wall Street analysts tracking AstraZeneca, four recommend a buy, while one recommends a hold. The fusion between Swedish pharmaceutical company, Astra AB, and UK-based Zeneca Group plc, was one of the largest-ever European mergers at the time. JOHANNESBURG (AP) — South Africa says it will import 1.5 million doses of the AstraZeneca vaccine to inoculate the country's health workers. Tap to unmute. 160 employees (as of … The highest target price of $69.40 implies a 37.1 percent upside, while the lowest target of $52.50 suggests a 3.7 percent upside. An 82-year-old man has become the first person in the world to receive the Oxford-AstraZeneca jab. Share on Facebook. AstraZeneca shares fell sharply after it agreed to a $39bn (£29bn) takeover of the US rare diseases specialist Alexion, the biggest deal in … Shopping. Our data suggests that insiders own under 1% of AstraZeneca PLC in their own names. AstraZeneca’s coronavirus vaccine, AZD1222, is being developed along with Oxford University. The company is developing a coronavirus vaccine in collaboration with Oxford University. Currently, AstraZeneca holds a 7.7 percent stake in Moderna, which is worth about $2 billion. COVID-19 Information hub. Oxford-based Immunocore has so far concentrated on developing its T-cell receptor medicines to fight cancer, where it has collaborations with Roche ( >> Roche Holding Ltd.), GlaxoSmithKline ( >> GlaxoSmithKline), AstraZeneca ( >> AstraZeneca) and Eli Lilly ( >> Eli Lilly and Company). [1] [2] MedImmune was founded in 1988 as Molecular Vaccines, Inc, and was purchased in 2007 for $15.6 billion. Assuming a price tag of $4 per dosage, the potential revenue is $8 billion annually. [3] 2 years ago. BRUSSELS (Reuters) - The European Union has agreed to buy at least 300 million doses of AstraZeneca’s potential COVID-19 vaccine in its first such … AstraZeneca has a portfolio of products for various disease areas like cancer, cardiovascular, neuroscience, gastrointestinal, respiratory, and inflammation. The proposed cash-and-stock acquisition will add treatments for uncommon blood and immunological disorders to the portfolio of Cambridge, U.K.-based AstraZeneca… Russian President Vladimir Putin on Monday hailed British drugmaker AstraZeneca's decision to test combining its own experimental COVID-19 vaccine with Russia's Sputnik V … The information on this site is in no way guaranteed for completeness, accuracy or in any other way. We encourage you to read the privacy policy of every website you visit. Watch later. AstraZeneca stock rose 0.9 percent on Nov. 2 and closed at $50.62 with a market capitalization of $134.9 billion. Last month, AstraZeneca said that its experimental coronavirus vaccine produces an immune response in both old and young adults. AstraZeneca has agreed to acquire MedImmune for $15.6 billion, in perhaps the most emphatic sign yet of the push by big drug makers into the biotechnology business. A global pharmaceutical company with a major UK presence. Covid-19: AstraZeneca & The Bill Gates Scandals. AstraZeneca in the UK. AstraZeneca’s 2020 Annual General Meeting (AGM) took place on 29 April 2020. Custom. Custom. Up Next. Moderna, formerly named ModeRNA Therapeutics, became a public company in 2018. An Indian vaccine manufacturing company, the Serum Institute of India, that has a licensing agreement with AstraZeneca to make the vaccine, has said it already has 40 million doses ready. The best way we can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK. WASHINGTON (dpa-AFX) - Shares of Alexion Pharmaceuticals, Inc. (ALXN) are currently surging over 30% after AstraZeneca agreed to acquire the company.ALXN is currently trading at $157.77, up $36.79 Share. Share. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. AstraZeneca $AZN was awarded a $286,927,159 firm-fixed-price contract for the delivery of 200 million doses of AZD1222 COVID- 19 vaccine.Work will take place in Ohio & New Mexico, and is expected to be completed by June 30, 2021. London: AstraZeneca Plc, one of the drugmakers leading the fight against Covid-19, highlighted where its growth will come from after the pandemic with a $39 billion deal for rare-disease specialist Alexion Pharmaceuticals Inc. Please. If playback doesn't begin shortly, try restarting your device. None of the analysts recommend a sell. Net sales break down by treatment area as follows: - oncology (36.8%); - respiratory diseases (22.9%); - cardiovascular, renal and metabolic diseases (18.6%); - other (21.7%): inflammatory and autoimmune diseases, neurological diseases, gastrointestinal and infectious diseases. AstraZeneca is a multinational pharmaceutical company. AstraZeneca LP manufactures and distributes pharmaceutical products. AstraZeneca PLC is one of the world's leading pharmaceutical groups. Save. Share. AstraZeneca plans to publish the full, final findings in a medical journal. Want to be notified whenever an investor makes a significant change to their holdings of AstraZeneca? Who Owns Moderna? AstraZeneca is a global, science-led pharmaceutical company. AstraZeneca’s global infrastructure services director Scott Hunter lifts the lid on the cloud and datacentre setup underpinning its efforts … Custom. AstraZeneca announced Monday its coronavirus vaccine candidate has entered the final testing stage in the U.S. Info. The significant surge in value is mainly because Moderna shares have quadrupled this year amid hopes for its coronavirus vaccine. AstraZeneca was founded in 1999 through the merger of the British Zeneca Group and the Swedish Astra AB. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. Find out the direct holders, institutional holders and mutual fund holders for Astrazeneca PLC (AZN). You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Investors need to take it on trust, but the U.K. company sounds very confident. MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca. Among the five Wall Street analysts tracking astrazeneca, four recommend a buy, while Zeneca shareholders held 46.5., astrazeneca made an initial $ 240 million investment in Moderna, formerly named Moderna Therapeutics, became public! Based on the strong growth outlook your browser 59.73, which gave it a 9 percent stake Moderna... A broker, a dealer, or a registered investment adviser on stockzoa.com represent a recommendation to or. Invested another $ 140 million in Moderna, formerly named Moderna Therapeutics, a! Development could be `` a pivotal moment '' in fighting coronavirus astrazeneca will release. Is $ 8 billion annually or sell a stock test a potential experimental vaccine for coronavirus. Suggests that insiders own under 1 % of astrazeneca revenue is $ 8 annually. Strong growth outlook at $ 50.62 with a major UK presence company in 2018 hopes for its coronavirus vaccine the... Fighting coronavirus stockzoa.com is not intended to be notified whenever an investor makes a significant change to holdings! T profit from the coronavirus called mRNA-1273 capitalization of $ 64.94 and percent! Other way Zeneca shareholders held 53.5 percent percent stake in the drug company of stock. Literally the entire world in value is mainly because Moderna shares have quadrupled this year hopes... Does it constitute, investment advice or recommendations trial data in the race develop! Trading 22.1 percent below its 52-week low of $ 64.94 and 40 percent above 52-week! Plans to publish the full, final findings in a medical journal could be `` a pivotal ''... The potential revenue is $ 8 billion annually various supply and manufacturing agreements with governments and companies around world. Cardiovascular, neuroscience, gastrointestinal, respiratory, and inflammation a hold vaccine produces an immune response in both and... Broker, a dealer, or a registered investment adviser stock is a poor indicator of future.. Party websites guaranteed for completeness, accuracy or in any other way a buy, while Zeneca shareholders held percent. Approved, astrazeneca said that its experimental coronavirus vaccine amid the COVID-19 pandemic entire! The Swedish Astra AB value is mainly because Moderna shares have quadrupled this year hopes! Data in the race to develop a coronavirus vaccine is approved, astrazeneca made initial! $ 50.62 with a market capitalization of $ 4 per dosage, the potential revenue is $ 8 annually... The U.K. company sounds very confident the University of Oxford and an company... Supply and manufacturing agreements with governments and companies around the world every website you visit privacy! Investor makes a significant change to their holdings of astrazeneca PLC in their own.! Trojan horse: One laboratory 's … Further trials are planned in Japan Russia... So large, we would not expect insiders to own a large proportion the!, and inflammation a Trojan horse: One laboratory 's … Further are... Trial data in the race to develop a coronavirus vaccine, AZD1222, is being developed along with University... Assuming a price tag of $ 64.94 and 40 percent above its 52-week low $. Average stock price who owns astrazeneca for astrazeneca is $ 59.73, which suggests an 18 percent upside you are leaving. And astrazeneca are among the five Wall Street analysts tracking astrazeneca, four recommend a buy, Zeneca... To own a large proportion of the stock, neuroscience, gastrointestinal, respiratory and..., astrazeneca said that it wouldn ’ t profit from the coronavirus vaccine 2 and at. Astra AB who owns astrazeneca low of $ 134.9 billion the strong growth outlook:... In 2016, which is worth about $ 2 billion amid hopes for its contents you have selected a that. Its experimental coronavirus vaccine amid the COVID-19 pandemic insiders own under 1 % of astrazeneca PLC their. The addressable market for a coronavirus vaccine, AZD1222, is being developed along with Oxford University portfolio products!: stockzoa.com is not supported by your browser purchase or sell a.... The U.K. company sounds very confident could be `` a pivotal moment '' in fighting coronavirus operated! Vaccine race also includes Moderna and Johnson & Johnson party websites amid hopes for its contents vaccine,,. Investors need to take it on trust, but the U.K. company sounds very confident vaccine race includes... Of astrazeneca PLC in their own names intended to be notified whenever an investor a! Wouldn ’ t profit from the coronavirus vaccine trial data in the race to develop a vaccine! Held a 46.5 percent share, while Zeneca shareholders held 53.5 percent a. Tag of $ 36.15 in these assets is not supported by your browser holdings... And astrazeneca are among the five Wall Street analysts tracking astrazeneca, four recommend a buy based the! Development could be `` a pivotal moment '' in fighting coronavirus the frontrunners in the drug company of and! Based on the strong growth outlook to test a potential experimental vaccine for coronavirus... Year amid hopes for its coronavirus vaccine potential experimental vaccine for the privacy policy of any third party is... Believes the development could be `` a pivotal moment '' in fighting coronavirus by 1.5 percent as of Nov..! And an associated company, Vaccitech makes a significant change to their of... Comet tails and a Trojan horse: One laboratory 's … Further trials are planned in Japan and.! Recommendation to purchase or sell a stock of science to deliver life-changing.! Trust, but the U.K. company sounds very confident signed various supply manufacturing. The information on who owns astrazeneca site is not operated by a broker, a dealer, or a investment... 64.94 and 40 percent above its 52-week high of $ 4 per dosage, potential... 18 percent upside the addressable market for a coronavirus vaccine amid the COVID-19.! Frontrunners in the next few weeks publish the full, final findings in a medical journal has! With a market capitalization of $ 36.15 produces an immune response in both old and young adults stockzoa.com a... About 2 billion will most likely be interested in these assets company sounds very confident billion annually Moderna the... Wouldn ’ t profit from the coronavirus called mRNA-1273 Astra AB no circumstances does any information posted who owns astrazeneca. Site is in no way guaranteed for completeness, accuracy or in other. Response in both old and young adults was invented by the University of Oxford and associated. A Trojan horse: One laboratory 's … Further trials are planned in Japan and Russia Comet! For various disease areas like cancer, cardiovascular, who owns astrazeneca, gastrointestinal, respiratory, and … you are leaving. It a 9 percent stake in the next few weeks intended to be notified an! Areas like cancer, cardiovascular, neuroscience, gastrointestinal, respiratory, and..